Skip to content
akaturk Academic measurement
Keywords YÖKSİS
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 91
YÖKSİS91 OpenAlex0
Projects 15
Books 1
Proceedings 31

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 7
h-index 5 Percentile in Türkiye: 66 #79 of 221 at their university by h-index
i10-index
5
Total citations
105
Top 32% in Türkiye
Per article
15.0
FWCI
2.68
1.00 = world average
World top 1%
0
World top 10%
3

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 86
  • Q1 21
  • Q2 50
  • Q3 14
  • Q4 1
WoS (JCR) 88
  • Q1 25
  • Q2 40
  • Q3 21
  • Q4 2
TR Index TR Index

4 articles

OpenAlex citation percentile
  • Top 1% 0
  • Top 10% 3
  • Avg 82.7%
  • n 7
Other counts

Scopus (SJR)

  • Excluding abstracts 85 Q1 21 Q2 49 Q3 14 Q4 1
  • YÖKSİS rows 86

WoS (JCR)

  • Excluding abstracts 87 Q1 25 Q2 40 Q3 20 Q4 2
  • YÖKSİS rows 88

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Journals with publications

42 journals

Article list

  1. 2025 Synthesis, Characterization, and Comprehensive In Vitro and In Silico Evaluation of the Anti‐Inflammatory Potential of Novel 1,2,3‐Triazole–Arylidenehydrazide/Thiazolidinone Hybrids Archiv der Pharmazie DOI 10.1002/ardp.70081 YÖKSİS SJR Q2 JCR Q2 OpenAlex 88.5%
  2. 2025 New 4-methanesulfonyloxy benzohydrazide derivatives as potential antioxidant and carbonic anhydrase I and II inhibitors: synthesis, characterization, molecular docking, dynamics & ADME studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.140937 YÖKSİS SJR Q2 JCR Q2
  3. 2025 Dual targeting of neuroblastoma and cholinesterase by morpholino/pyrrolidino-sulfonyl-indole thiosemicarbazones: Synthesis, characterization, enzyme inhibition, cytotoxicity, docking and dynamics studies Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.109252 YÖKSİS SJR Q1 JCR Q1
  4. 2025 Synthesis, antiproliferative activity targeting lung cancer and in silico studies of hydroxypiperidine substituted thiosemicarbazones Scientific Reports DOI 10.1038/s41598-025-18735-y YÖKSİS SJR Q1 JCR Q1
  5. 2025 New Quinazolin‐4(3H)‐One–Thiazolidine‐2,4‐Dione Hybrids as Dual Inhibitors of α‐Glycosidase and Aldose Reductase: The Synthetic, In Vitro, and In Silico Approaches Journal of Biochemical and Molecular Toxicology DOI 10.1002/jbt.70412 YÖKSİS SJR Q2 JCR Q2
  6. 2025 Detection and in silico evaluation of undeclared venlafaxine and clomethiazole in a counterfeit herbal product marketed for alcohol withdrawal syndrome Journal of Pharmaceutical and Biomedical Analysis DOI 10.1016/j.jpba.2025.117189 YÖKSİS SJR Q2 JCR Q2
  7. 2025 Targeting Lung Cancer: Synthesis, Characterization, Enzyme Inhibition, and Antiproliferative Activity of 1H‐Benzo[f]chromen‐1‐One‐Thiosemicarbazones Supported by Molecular Docking Archiv der Pharmazie DOI 10.1002/ardp.70116 YÖKSİS SJR Q2 JCR Q2
  8. 2025 Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer’s key enzymes: From synthesis to inhibition Computational Biology and Chemistry DOI 10.1016/j.compbiolchem.2025.108683 YÖKSİS SJR Q2 JCR Q1
  9. 2025 Bioactive phenolic contents of Scorzonera ketzkhowelii Sosn. ex Grossh. (Asteraceae) with comprehensive in vitro and in silico studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.140436 YÖKSİS SJR Q2 JCR Q2 OpenAlex 86.0%
  10. 2025 Synthesis, cytotoxic evaluation, and in silico studies of novel benzenesulfonamide-thiazolidinone derivatives against colorectal carcinoma Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.140153 YÖKSİS SJR Q2 JCR Q2
  11. 2025 Quinazolin‐4(3H)‐One‐Based New Glitazones as Dual Inhibitors of α‐Glucosidase and Aldose Reductase: Comprehensive Approaches for Managing Diabetes Mellitus and Its Complications Archiv der Pharmazie DOI 10.1002/ardp.70033 YÖKSİS SJR Q2 JCR Q2
  12. 2025 Design, synthesis, and cytotoxic evaluation of new thiosemicarbazone/thiazolidin-4-one derivatives on PC3 cells Future Medicinal Chemistry DOI 10.1080/17568919.2025.2592533 YÖKSİS SJR Q3 JCR Q3
  13. 2025 Design, synthesis, and computational insights into 3-acetyl-8-methoxy coumarin hybrids as potential anti-alzheimer’s agents Scientific Reports DOI 10.1038/s41598-025-28665-4 YÖKSİS SJR Q1 JCR Q1
  14. 2025 Synthesis and evaluation of aldose reductase inhibition of new thiazolidine-quinazoline hybrids through in vitro and in silico approaches Computational Biology and Chemistry DOI 10.1016/j.compbiolchem.2025.108486 YÖKSİS SJR Q2 JCR Q1
  15. 2025 Synthesis, Characterization and In Vitro and In Silico Biological Evaluation of New Mannich-Based Rhodanine and Thiazolidine-2,4-dione Derivatives as Potential Anti-Lung-Cancer Agents Synlett DOI 10.1055/a-2541-1072 YÖKSİS SJR Q3 JCR Q3
  16. 2025 Using microwave-assisted extraction with advanced artificial intelligence models for predicting tannins in black pepper (Piper nigrum L.) Journal of Applied Research on Medicinal and Aromatic Plants DOI 10.1016/j.jarmap.2024.100594 YÖKSİS SJR Q2 JCR Q2
  17. 2025 Harnessing natures building blocks: potent and safe urease inhibition by simple amino acids Bioorganic Chemistry DOI 10.1016/j.bioorg.2025.109419 YÖKSİS SJR Q1 JCR Q1
  18. 2025 Inhibition Effects of Some Phenolic Anthraquinone Derivatives on Lactoperoxidase Activity: A Detailed in Vitro and in Silico investigation Food Biophysics DOI 10.1007/s11483-025-09957-8 YÖKSİS SJR Q2 JCR Q2
  19. 2025 Synthesis, biological evaluation, and in silico studies of phenyl naphthalene-2-sulfonate derived thiosemicarbazones as potential carbonic anhydrase inhibitors Bioorganic Chemistry DOI 10.1016/j.bioorg.2024.108118 YÖKSİS SJR Q1 JCR Q1
  20. 2025 Exploring highly selective polymethoxy fenamate isosteres as novel anti-prostate cancer agents: Synthesis, biological activity, molecular docking, molecular dynamics, and ADME studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.139519 YÖKSİS SJR Q2 JCR Q2

Back to academicians